1. Home
  2. SATL vs NEO Comparison

SATL vs NEO Comparison

Compare SATL & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Satellogic Inc.

SATL

Satellogic Inc.

HOLD

Current Price

$10.51

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$9.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SATL
NEO
Founded
2010
2001
Country
United States
United States
Employees
154
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
SATL
NEO
Price
$10.51
$9.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
8
Target Price
$5.50
$13.38
AVG Volume (30 Days)
7.4M
2.0M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$88.89
$10.63
Revenue Next Year
$56.98
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$4.72
52 Week High
$10.19
$13.74

Technical Indicators

Market Signals
Indicator
SATL
NEO
Relative Strength Index (RSI) 70.43 60.46
Support Level $3.18 $7.42
Resistance Level N/A $10.82
Average True Range (ATR) 0.96 0.40
MACD 0.20 0.04
Stochastic Oscillator 96.80 89.45

Price Performance

Historical Comparison
SATL
NEO

About SATL Satellogic Inc.

Satellogic Inc is a vertically integrated Earth observation company that designs, manufactures, and operates satellite systems, delivering decision-grade insights at scale to government and commercial customers. Through an end-to-end production and operations model, it provides governments with flexible options across their journey toward sovereign Earth observation. From access to high-frequency imagery and managed space systems to full satellite ownership, to supporting autonomous data availability and long-term technological independence. It has monitoring and alert-driven workflows that help defense and intelligence agencies, civil governments, and commercial operators transition from reactive tasking to proactive decision-making, providing mission-critical data when needed.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: